Compare MCS & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCS | YDES |
|---|---|---|
| Founded | 1935 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 590.8M | 543.0M |
| IPO Year | 1994 | N/A |
| Metric | MCS | YDES |
|---|---|---|
| Price | $19.40 | $5.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.33 | N/A |
| AVG Volume (30 Days) | ★ 121.0K | 28.5K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.66% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.77 | N/A |
| Revenue | ★ $758,458,000.00 | N/A |
| Revenue This Year | $12.05 | N/A |
| Revenue Next Year | $3.15 | N/A |
| P/E Ratio | $25.74 | ★ N/A |
| Revenue Growth | ★ 3.11 | N/A |
| 52 Week Low | $12.85 | $5.00 |
| 52 Week High | $20.02 | $25.00 |
| Indicator | MCS | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 64.57 | 31.56 |
| Support Level | $14.66 | N/A |
| Resistance Level | N/A | $9.11 |
| Average True Range (ATR) | 0.59 | 0.70 |
| MACD | 0.09 | -0.09 |
| Stochastic Oscillator | 78.22 | 2.00 |
Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.